QNCX · Quince Therapeutics, Inc.
$33.53
+1.03 (+3.17%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, the Company concluded that substantial doubt about the Company's ability to continue as a going concern continues to exist within one year after the date these financial statements are available to be issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$35.29M
Shares
1.02M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Dirk Thye | Chief Executive Officer and Chief Medical Officer | $2,493,625 |
| Brendan Hannah | Chief Operating Officer, Chief Business Officer and Chief Compliance Officer | $1,263,075 |
| Charles Ryan | President | $1,144,100 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dirk Thye | Chief Executive Officer and Chief Medical Officer | $2,732,125 |
| Brendan Hannah | Chief Operating Officer, Chief Business Officer and Chief Compliance Officer | $1,365,875 |
| Charles Ryan | President | $893,050 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Karen Smith | M.D., Ph.D. Former Chief Medical Officer | $1,347,920 |
| Dirk Thye | Chief Executive Officer and Chief Medical Officer | $1,330,500 |
| Brendan Hannah | Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | $847,500 |
| Charles Ryan | President | $817,556 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Casey C. Lynch | Former President and Chief Executive Officer | $5,167,258 |
| Dirk Thye | Chief Executive Officer and Chief Medical Officer | $4,968,477 |
| Karen Smith | M.D., Ph.D. Former Chief Medical Officer | $3,485,274 |
| Christopher Lowe | Former Interim Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer and Treasurer | $3,400,870 |
| Leslie Holsinger | Former Executive Vice President of Preclinical Development | $3,236,125 |
| Caryn McDowell | Former Chief Legal and Administrative Officer | $3,112,459 |
| Brendan Hannah | Chief Business Officer, Chief Operating Officer and Chief Compliance Officer | $1,152,926 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Christopher Lowe | Former Interim Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer and Treasurer | $2,123,652 |
| Casey C. Lynch | Former President and Chief Executive Officer | $887,344 |
| Caryn McDowell | Former Chief Legal and Administrative Officer | $603,850 |
| Leslie Holsinger | Former Executive Vice President of Preclinical Development | $603,850 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kristen Gafric | Senior Vice President, Legal and Administration, and Secretary | $1,952,937 |
| Michael Detke | Chief Medical Officer | $1,100,168 |
| Casey C. Lynch | Chief Executive Officer | $559,952 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Casey C. Lynch | Chief Executive Officer | $917,333 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Keith R. Fandrick | Chief Operating Officer | Appointed | 2026-07-31 |
| John Militello | Principal Accounting Officer | Appointed | 2026-07-31 |
| John Militello | Chief Financial Officer | Appointed | 2026-07-31 |
| Brigette Roberts | Chief Executive Officer | Appointed | 2026-07-31 |
| Brendan Hannah | Chief Compliance Officer | Resigned | 2026-07-31 |
| Brendan Hannah | Chief Business Officer | Resigned | 2026-07-31 |
| Dirk Thye | member of the Company's board of directors | Resigned | 2026-07-31 |
| Brendan Hannah | Chief Operating Officer | Resigned | 2026-07-31 |
| Dirk Thye | Chief Medical Officer | Resigned | 2026-07-31 |
| Dirk Thye | Chief Executive Officer | Resigned | 2026-07-31 |
| Brigette Roberts, M.D. | Chief of Corporate Affairs | Appointed | 2026-05-18 |
| Brigette Roberts, M.D. | Class III director | Appointed | 2026-05-18 |
| June Bray | Class I director | Appointed | 2026-04-22 |
| Una Ryan | member of the Board of Directors | Resigned | 2026-02-02 |
| Margi McLoughlin | member of the Board of Directors | Resigned | 2026-02-02 |
| June Bray | member of the Board of Directors | Resigned | 2026-02-02 |
| Luca Benatti | member of the Board of Directors | Resigned | 2026-02-02 |
| Rajiv Patni | member of the Board of Directors | Resigned | 2026-02-02 |
| Brendan Hannah | Chief Operating Officer | Appointed | 2023-10-26 |
| Charles S. Ryan | President | Appointed | 2023-09-06 |
| Luca Benatti | director | Appointed | 2023-07-24 |
| Philip Low | member of the Board of Directors | Resigned | 2023-03-28 |
| Brendan Hannah | principal financial officer and principal accounting officer | Appointed | 2023-03-03 |
| Ted Monohon | Chief Accounting Officer and Vice President of Finance, including as the principal financial officer and principal accounting of | Resigned | 2023-03-03 |
| Marwan Sabbagh | member of the Board of Directors | Resigned | 2022-09-30 |
Key facts
CIK
1662774
CUSIP
22053A305
13F (30d)
32 filings
28 filers
Visit website
Investor relations